Direct oral anticoagulants: a review on the current role and scope of reversal agents-Reference-Cited by-同舟云学术

Direct oral anticoagulants: a review on the current role and scope of reversal agents

Published:2019-09-11 Issue:2 Volume:49 Page:271-286
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Chaudhary Rahul^ORCID,Sharma Tushar,Garg Jalaj,Sukhi Ajaypaul,Bliden Kevin,Tantry Udaya,Turagam Mohit,Lakkireddy Dhanunjaya,Gurbel Paul

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-019-01954-2.pdf

Reference89 articles.

1. Wardrop D, Keeling D (2008) The story of the discovery of heparin and warfarin. Br J Haematol 141(6):757–763. https://doi.org/10.1111/j.1365-2141.2008.07119.x

2. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW (2019) AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients With atrial fibrillation. Circulation. https://doi.org/10.1161/cir.0000000000000665

3. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic Therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315–352. https://doi.org/10.1016/j.chest.2015.11.026

4. Sandau KE, Funk M, Auerbach A, Barsness GW, Blum K, Cvach M, Lampert R, May JL, McDaniel GM, Perez MV, Sendelbach S, Sommargren CE, Wang PJ, American Heart Association Council, American Heart Association Council on C, Stroke N, Council on Clinical C, Council on Cardiovascular Disease in the Y (2017) Update to practice standards for electrocardiographic monitoring in hospital settings: a scientific statement from the American Heart Association. Circulation 136(19):e273–e344. https://doi.org/10.1161/CIR.0000000000000527

5. Benjamin EM, Klugman RA, Luckmann R, Fairchild DG, Abookire SA (2013) Impact of cardiac telemetry on patient safety and cost. Am J Manag Care 19(6):e225–e232

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy;Journal of the Formosan Medical Association;2024-09

2. Safety and Outcomes with Direct Oral Anticoagulants Versus Vitamin-K Antagonists in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression;Cardiology in Review;2024-06-04

3. Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy;Clinical Pharmacokinetics;2024-03

4. Principles for management of hip fracture for older adults taking direct oral anticoagulants: an international consensus statement;Anaesthesia;2024-02-06

5. Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis;Rational Pharmacotherapy in Cardiology;2024-02-01